Cite
HARVARD Citation
Alten, R. et al. (n.d.). AB0412 Less than 5% of real-life patients who switch from iv to sc abatacept in real-world clinical practice subsequently switch back to the iv formulation. Annals of the rheumatic diseases. pp. 1193-1194. [Online].